ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

RFA Available: Chemoprevention Trials

August 5, 1994

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

NIH Challenge Grant Announcement

March 6, 2009

RFPs Go Out To Cooperative Groups for Community Programs

April 9, 1976